Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Arix Bioscience
Life Sciences
With high risk can come high reward
19 Feb 2020
Advanced Oncotherapy
Life Sciences
Confidence in LIGHT gaining momentum
By
Dr Martin Hall
17 Feb 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Tissue Regenix
Life Sciences
Restructured to satisfy product demand
06 Feb 2020
genedrive Plc
Life Sciences
Western market progress but developing markets difficult
05 Feb 2020
Shield Therapeutics Plc
Life Sciences
Good demand for Feraccru in Europe
By
Dr Martin Hall
28 Jan 2020
Allergy Therapeutics plc
Life Sciences
Sales growth well above market average
By
Dr Martin Hall
16 Jan 2020
Shield Therapeutics Plc
Life Sciences
Taking on China
14 Jan 2020
Advanced Oncotherapy
Life Sciences
Proving the accuracy and superiority of minibeams
04 Dec 2019
Diurnal Group Plc
Life Sciences
Successful DITEST Phase I trial outcome
26 Nov 2019
genedrive Plc
Life Sciences
Regulatory hurdle leaped: hearing loss assay
21 Nov 2019
Incanthera Ltd
Life Sciences
Realising near-term value in oncology
20 Nov 2019
Prev
1
...
6
7
8
9
10
...
22
Next
